Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea.
Post-COVID syndrome leads to cognitive impairment, depression, and fatigue due to neuroinflammation, oxidative stress, and mitochondrial dysfunction. Herbal drugs like Ginkgo biloba and Rhodiola rosea may improve cognition, reduce fatigue and depression, but more research is required.
- Mueller JK and Müller WE (2024).
- J Neural Transm (Vienna).
- PubMed:
- 38347175